Safety and Efficacy of Botulinum Toxin A in Patients With Posttraumatic Headache — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Safety and Efficacy of Botulinum Toxin A in Patients With Posttraumatic Headache — Stella

Recruiting

Back to Posttraumatic Headache trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

Denmark

Danish Headache Center, Glostrup Municipality

Key details

Phase

Large-scale testing

Sponsor

Danish Headache Center

Enrollment target

~80 participants

Started

January 2025

Primary completion

March 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 80 Years

Last updated February 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov